Exabis Library
Welcome to the e-CCO Library!
OP006: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP007: α4β7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:21 PM by ECCO Administrator
1
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP007: Comprehensive epigenome-wide DNA methylation profiling in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP008: An innovative treatment for refractory perianal fistulas in Crohn's disease: local micro reinjection of autologous fat and adipose derived stromal vascular fraction
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP008: An innovative treatment for refractory perianal fistulas in Crohn’s Disease: Local micro reinjection of autologous fat and adipose derived stromal vascular fraction (ClinicalTrials. gov NCT02520843, Eudract: 2013-002602-31)
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:24 PM by ECCO Administrator
1
OP008: Detection of mucosal healing with a serum marker panel in adalimumab-treated patients with ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP008: Genotype-phenotype analysis across 130 422 genetic variants identifies RSPO3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP009: A combination of clinical, serological, and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP009: Gene-microbiome interactions underlying the onset and the clinical phenotypes of inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
1
OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP010: Azathioprine dose reduction in patients with inflammatory bowel disease on combination therapy: a prospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1